Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

30.72 -0.05 (-0.16%)
Official Closing Price Updated: 4:10 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,677,323
Open 30.69
Bid (Size) 30.74 (2)
Ask (Size) 30.75 (39)
Prev. Close 30.77
Today's Range 30.44 - 30.93
52wk Range 25.20 - 37.19
Shares Outstanding 5,606,688,356
Dividend Yield 5.34%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
(PFE) - Analyzing Pfizer's Short Interest
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga

Performance

YTD
+3.33%
+3.33%
1 Month
+9.79%
+9.79%
3 Month
+19.81%
+19.81%
6 Month
+11.79%
+11.79%
1 Year
-14.81%
-14.81%

More News

Read More
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Via Benzinga
Prediction: This Will Be Pfizer's Next Big Move
Via The Motley Fool
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Via Benzinga
Topics Economy
Exposures Interest Rates
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold Forever
Via The Motley Fool
Pfizer's Options: A Look at What the Big Money is Thinking
Via Benzinga
2 Incredibly Cheap Healthcare Stocks to Buy Now
Via The Motley Fool
2 High-Yield Dividend Stocks That Could Shine in 2025
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $200
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
Via The Motley Fool
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
Via Benzinga
Get Your Money Out of These 3 Dividend Stocks by 2025
Via InvestorPlace
What's Going On With Pfizer Stock Thursday?
Via Benzinga
European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
From Pfizer Inc.
Via Business Wire
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
Via FinancialNewsMedia
Exposures Product Safety
7 Dividend Stocks to Hold On Tight to for the Next Decade
Via InvestorPlace
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
Via The Motley Fool
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
From FN Media Group LLC
Via GlobeNewswire
Beware, Wegovy -- Pfizer Is Working on a Competitor
Via The Motley Fool
Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?
Via InvestorPlace
Sangamo Stock Spikes As Pfizer Partnership Meets Goal In Late-Stage Study
Via Benzinga
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer
Via The Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.